Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-05-20 @ 3:51 AM
Study NCT ID:
NCT06659120
Status:
RECRUITING
Last Update Posted:
2024-10-26
First Post:
2024-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2024-00388
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None